Eloxatin FDA Approval History
FDA Approved: Yes (First approved August 9, 2002)
Brand name: Eloxatin
Generic name: oxaliplatin
Dosage form: Injection
Company: Sanofi-Synthelabo
Treatment for: Colorectal Cancer
Eloxatin (oxaliplatin injection) platinum-based drug used in combination with infusional 5-fluorouracil /leucovorin for the treatment of advanced carcinoma of the colon or rectum.
Development timeline for Eloxatin
| Date | Article |
|---|---|
| Jan 31, 2005 | Approval Sanofi-aventis Receives FDA Approval for New Eloxatin Formulation |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
